Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial
暂无分享,去创建一个
Q. Bassat | C. Menéndez | A. Bacchieri | H. Tinto | U. d’Alessandro | I. Valéa | A. Talisuna | P. Sasi | S. Borrmann | M. Mulenga | Michael Nambozi | P. Piola | D. Ubben | M. Corsi | C. Nabasumba | M. Nambozi
[1] Organización Mundial de la Salud. Guidelines for the treatment of malaria , 2010 .
[2] R. Price,et al. Antimalarial therapies in children from Papua New Guinea. , 2009, The New England journal of medicine.
[3] P. Siba,et al. A trial of combination antimalarial therapies in children from Papua New Guinea. , 2008, The New England journal of medicine.
[4] T. Travers,et al. Pharmacokinetics of the antimalarial drug piperaquine in healthy Vietnamese subjects. , 2008, The American journal of tropical medicine and hygiene.
[5] David L. Smith,et al. Benefits of using multiple first-line therapies against malaria , 2008, Proceedings of the National Academy of Sciences.
[6] M. Ashton,et al. The influence of food on the pharmacokinetics of piperaquine in healthy Vietnamese volunteers. , 2008, Acta tropica.
[7] P. Rosenthal,et al. Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treating Uncomplicated Malaria: A Randomized Trial to Guide Policy in Uganda , 2008, PloS one.
[8] N. White. How antimalarial drug resistance affects post-treatment prophylaxis , 2008, Malaria Journal.
[9] P. Rosenthal,et al. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] F. Nosten,et al. Artemisinin-based combination treatment of falciparum malaria. , 2007, The American journal of tropical medicine and hygiene.
[11] U. d’Alessandro,et al. A Randomised Controlled Trial to Assess the Efficacy of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Falciparum Malaria in Peru , 2007, PloS one.
[12] R. Price,et al. Clinical and Pharmacological Determinants of the Therapeutic Response to Dihydroartemisinin-Piperaquine for Drug-Resistant Malaria , 2007, Antimicrobial Agents and Chemotherapy.
[13] H. Myint,et al. Efficacy and safety of dihydroartemisinin-piperaquine. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[14] P. Rosenthal,et al. Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial , 2007, PLoS clinical trials.
[15] R. Price,et al. Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] R. Price,et al. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison , 2007, The Lancet.
[17] C. Karema,et al. Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[18] K. Stepniewska,et al. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison , 2006, The Lancet.
[19] U. d’Alessandro,et al. Pharmacovigilance of antimalarial treatment in Africa: is it possible? , 2006, Malaria Journal.
[20] Douglas G Altman,et al. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. , 2006, JAMA.
[21] T. Davis,et al. Effects of a High-Fat Meal on the Relative Oral Bioavailability of Piperaquine , 2005, Antimicrobial Agents and Chemotherapy.
[22] R. Hallett,et al. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial , 2005, The Lancet.
[23] Inacio Mandomando,et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial , 2004, The Lancet.
[24] Nicholas J White,et al. Antimalarial drug resistance. , 2004, The Journal of clinical investigation.
[25] P. Alonso,et al. Efficacy of chloroquine, amodiaquine, sulphadoxine–pyrimethamine and combination therapy with artesunate in Mozambican children with non‐complicated malaria , 2004, Tropical medicine & international health : TM & IH.
[26] S. Satpathy,et al. Severe falciparum malaria , 2004, Indian journal of pediatrics.
[27] U. d’Alessandro,et al. History, Dynamics, and Public Health Importance of Malaria Parasite Resistance , 2004, Clinical Microbiology Reviews.
[28] R. Snow,et al. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria , 2003 .
[29] A. Talisuna,et al. Clinical efficacy of chloroquine or sulfadoxine-pyrimethamine in children under five from south-western Uganda with uncomplicated falciparum malaria. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[30] N. White,et al. Pharmacokinetics and Pharmacodynamics of Lumefantrine (Benflumetol) in Acute Falciparum Malaria , 2000, Antimicrobial Agents and Chemotherapy.
[31] K. Raynes. Bisquinoline antimalarials: their role in malaria chemotherapy. , 1999, International journal for parasitology.
[32] R. Paru,et al. Mating patterns in malaria parasite populations of Papua New Guinea. , 1995, Science.
[33] P Roebruck,et al. Comparison of tests and sample size formulae for proving therapeutic equivalence based on the difference of binomial probabilities. , 1995, Statistics in medicine.
[34] O. Doumbo,et al. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. , 1995, The American journal of tropical medicine and hygiene.
[35] R. Carter,et al. Frequency of cross-fertilization in the human malaria parasite Plasmodium falciparum , 1993, Parasitology.
[36] J. Philpott,et al. Severe falciparum malaria. , 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.